Early research (Phase 1)Study completedNCT02475213
What this trial is testing
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
Who this might be right for
MelanomaHead and Neck CancerNon Small Cell Lung Cancer+1 more
MacroGenics 146